EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will targetimproving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).

Biotechnology

Therapeutics

EnClear Therapies

EnClear Therapies' headquarters in Cambridge, MA, United States

Description

People (2)

Manuel N.

Marcie Glicksman

Jobs